These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32349463)

  • 1. The Unusual Case of Fibroma of Tendon Sheath in a Young Girl with Turner Syndrome Undergoing Growth Hormone Treatment.
    Hong YH; Kim DG; Lee JH; Jung MJ; Choi CY
    J Clin Res Pediatr Endocrinol; 2021 Feb; 13(1):104-108. PubMed ID: 32349463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroma of tendon sheath of the hand in a 3-year-old boy: a case report.
    Shibayama H; Matsui Y; Kawamura D; Urita A; Ishii C; Kamishima T; Nishida M; Shimizu A; Iwasaki N
    BMC Musculoskelet Disord; 2020 Nov; 21(1):732. PubMed ID: 33172434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of growth hormone treatment on height in Turner syndrome: results of a 6-year multicentre study in Japan. Committee for the Treatment of Turner Syndrome.
    Takano K; Shizume K; Hibi I; Ogawa M; Okada Y; Suwa S; Tanaka T; Hizuka N
    Horm Res; 1995; 43(4):141-3. PubMed ID: 7750916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-year results of treatment with methionyl human growth hormone in children with Turner syndrome. Dutch Growth Hormone Working Group.
    Rongen-Westerlaken C; Fokker MH; Wit JM; De Muinck Keizer-Schrama SM; Otten BJ; Oostdijk W; Delemarre van den waal HA; Gons MH; Bot A
    Acta Paediatr Scand; 1990; 79(6-7):658-63. PubMed ID: 2386058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth response and levels of growth factors after two years growth hormone treatment are similar for a once and twice daily injection regimen in girls with Turner syndrome. (Dutch Working Group on Growth Hormone).
    van Teunenbroek A; de Muinck Keizer-Schrama S; Stijnen T; Waelkens J; Wit JM; Vulsma T; Gerver WJ; Reeser H; Delemarre-van de Waal H; Jansen M; Drop S
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):451-9. PubMed ID: 9196608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of two years of growth hormone treatment followed by combined growth hormone and oestradiol in Turner syndrome. The Norwegian Turner Study Group.
    Knudtzon J; Aarskog D
    Horm Res; 1993; 39 Suppl 2():7-17. PubMed ID: 8395456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbohydrate metabolism during growth hormone treatment and after discontinuation of growth hormone treatment in girls with Turner syndrome treated with once or twice daily growth hormone injections.
    Sas T; de Muinck Keizer-Schrama S; Aanstoot HJ; Stijnen T; Drop S
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):741-7. PubMed ID: 10848879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of growth hormone therapy on adult height of children with Turner syndrome.
    Hsu PY; Tung YC; Tsai WY; Lee JS; Hsiao PH
    J Formos Med Assoc; 2008 Sep; 107(9):704-9. PubMed ID: 18796360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone treatment in Turner syndrome: results of a multicentre study in Japan. The Committee for the Treatment of Turner Syndrome.
    Takano K; Shizume K; Hibi I; Ogawa M; Okada Y; Suwa S; Tanaka T
    Horm Res; 1993; 39 Suppl 2():37-41. PubMed ID: 8359787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary thyroid carcinoma after recombinant GH therapy for Turner syndrome.
    Cabanas P; García-Caballero T; Barreiro J; Castro-Feijóo L; Gallego R; Arévalo T; Cañete R; Pombo M
    Eur J Endocrinol; 2005 Oct; 153(4):499-502. PubMed ID: 16189169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with growth hormone therapy in Turner syndrome in a single centre: low total height gain, no further gains after puberty onset and unchanged body proportions.
    Schweizer R; Ranke MB; Binder G; Herdach F; Zapadlo M; Grauer ML; Schwarze CP; Wollmann HA
    Horm Res; 2000; 53(5):228-38. PubMed ID: 11150884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroma of tendon sheath of the hand: a series of 20 patients with 23 tumours.
    Al-Qattan MM
    J Hand Surg Eur Vol; 2014 Mar; 39(3):300-5. PubMed ID: 23212985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GH assessment and three years' hGH therapy in girls with Turner syndrome.
    Pasquino AM; Bernardini S; Cianfarani S; Mancuso G; Marchione SA; Passèri F; Pucarelli I; Spadoni GL
    Horm Res; 1992; 38(3-4):120-4. PubMed ID: 1306842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G; Baur F; Schweizer R; Ranke MB
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Jansen M; Otten BJ; Delemarre-van de Waal HA; Vulsma T; Wit JM; Rouwé CW; Reeser HM; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with two growth hormone regimens in girls with Turner syndrome: final height results. Dutch Growth Hormone Working Group.
    Massa G; Otten BJ; de Muinck Keizer-Schrama SM; Delemarre-van de Waal HA; Jansen M; Vulsma T; Oostdijk W; Waelkens JJ; Wit JM
    Horm Res; 1995; 43(4):144-6. PubMed ID: 7750917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status.
    Gravholt CH; Svenstrup B; Bennett P; Sandahl Christiansen J
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):791-800. PubMed ID: 10468952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final height in Turner syndrome patients treated with growth hormone.
    Pasquino AM; Passeri F; Municchi G; Segni M; Pucarelli I; Larizza D; Bossi G; Severi F; Galasso C
    Horm Res; 1996; 46(6):269-72. PubMed ID: 8982737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morning versus evening administration of estradiol to girls with turner syndrome receiving growth hormone: impact on growth hormone and metabolism. A randomized placebo-controlled crossover study.
    Naeraa RW; Gravholt CH; Kastrup KW; Svenstrup B; Christiansen JS
    Acta Paediatr; 2001 May; 90(5):526-31. PubMed ID: 11430712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.